• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION STERLING SL; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION STERLING SL; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number 24702
Device Problems Material Puncture/Hole (1504); Difficult to Advance (2920)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/22/2021
Event Type  malfunction  
Event Description
It was reported that the guidewire perforated the catheter shaft.A 2.0mm x 100mm x 150cm sterling sl balloon catheter was selected for percutaneous transluminal angioplasty (pta).The 99% stenosed, severely calcified and severely tortuous lesion was located in an artery below the knee (btk).There was difficulty advancing the balloon through the lesion.The balloon was removed to exchange for a lower profile balloon.During removal, they observed the non-boston scientific guidewire was protruding through the shaft proximal to the balloon.The procedure was completed with another device.There were no patient complications.
 
Manufacturer Narrative
Device eval by mfr: the returned product consisted of a sterling sl balloon catheter.The outer shaft, inner shaft, balloon and tip were visually and microscopically examined.Visual examination revealed multiple kinks along the shaft.Microscopic examination revealed a hole in the guidewire lumen and inflation lumen 34mm from the tip.Inspection of the remainder of the device presented no other damage or irregularities.
 
Event Description
It was reported that the guidewire perforated the catheter shaft.A 2.0mm x 100mm x 150cm sterling sl balloon catheter was selected for percutaneous transluminal angioplasty (pta).The 99% stenosed, severely calcified and severely tortuous lesion was located in an artery below the knee (btk).There was difficulty advancing the balloon through the lesion.The balloon was removed to exchange for a lower profile balloon.During removal, they observed the non-boston scientific guidewire was protruding through the shaft proximal to the balloon.The procedure was completed with another device.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERLING SL
Type of Device
CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12774873
MDR Text Key280820607
Report Number2134265-2021-14009
Device Sequence Number1
Product Code DQY
UDI-Device Identifier08714729782216
UDI-Public08714729782216
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
K093720
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/08/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/28/2023
Device Model Number24702
Device Catalogue Number24702
Device Lot Number0026710062
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/19/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/08/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/28/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-